Feasibility and safety study of ultrasound-guided percutaneous microwave ablation for sub-cardiac liver cancers without artificial ascites assistance
British Journal of Radiology · 2024
DOI: 10.1093/bjr/tqae169 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Radiology, 2024. Verfasst von Qiqi Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Ultrasonics, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, Guangdong Province, 518033, China. Hauptthemen laut MEDLINE: Liver Neoplasms, Microwaves, Feasibility Studies, Ultrasonography, Interventional. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation, Shenzhen Science and Technology Program.
Abstract (Originalsprache)
Objectives
To investigate the efficacy and safety of ultrasound (US)-guided microwave ablation (MWA) without artificial ascites (AA) inpatients with sub-cardiac (SC) liver cancers.
Methods
This retrospective study included patients with the left lobe and caudate lobe of the liver cancer who underwent US-guided MWA in our institute from January 2020 to December 2022. According to whether the target lesion was located ≤5 mm from the pericardium, patients were divided into the SC group and the non-sub-cardiac (NSC) group. In the SC group, AA was not employed during the ablation procedure. The results of technical success, technical efficiency, local tumour progression (LTP), and major complications were recorded.
Results
A total of 79 patients with 87 lesions were enrolled. There were 38 patients with 38 lesions in the SC group and 41 patients with 49 lesions in the NSC group. The median follow-up of all patients was 15 (range, 3-44) months. There was no significant difference in technical success rates (100% vs 100%), technique efficiency rates (100% vs 95.7%), LTP rates (2.63% vs 0%,), and major complication rates (2.63% vs 7.32%) between the SC group and the NSC group (P > .05). No cardiac-related complications occurred.
Conclusions
US-guided MWA without AA for SC liver cancers was safe and effective. Advances in knowledge The clinical prognosis of thermal ablation without AA in the treatment of SC liver cancers is still unclear. The finding of this study provided evidence supporting the efficacy and safety of US-guided MWA without AA for treating this tricky location.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Ultrasonics, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, Guangdong Province, 518033, China.
- Department of Radiology, Peking University Shenzhen Hospital, Shenzhen, Guangdong Province, 518036, China.
ORCID-Profile: Erjiao Xu
Förderung
- National Natural Science Foundation of China
- Guangdong Basic and Applied Basic Research Foundation
- Shenzhen Science and Technology Program
- Futian Healthcare Research
Zitieren
APA
Liu, Q., Liang, S., Liu, H., Luo, L., Wu, S., Guan, S., Liu, Y., Yan, R., & Xu, E. (2024). Feasibility and safety study of ultrasound-guided percutaneous microwave ablation for sub-cardiac liver cancers without artificial ascites assistance. British Journal of Radiology. https://doi.org/10.1093/bjr/tqae169
Vancouver
Liu Q, Liang S, Liu H, Luo L, Wu S, Guan S, et al. Feasibility and safety study of ultrasound-guided percutaneous microwave ablation for sub-cardiac liver cancers without artificial ascites assistance. British Journal of Radiology. 2024. doi:10.1093/bjr/tqae169
BibTeX
@article{Liu2024,
author = {Liu, Qiqi and Liang, Shuang and Liu, Huahui and Luo, Liping and Wu, Shanshan and Guan, Sainan and Liu, Ying and Yan, Ronghua and Xu, Erjiao},
title = {Feasibility and safety study of ultrasound-guided percutaneous microwave ablation for sub-cardiac liver cancers without artificial ascites assistance},
journal = {British Journal of Radiology},
year = {2024},
doi = {10.1093/bjr/tqae169}
}
EUVIMED